The gut microbiome: a new pathway to obesity prevention and metabolic health
Completed
- Conditions
- ObesityMetabolic Health
- Registration Number
- ACTRN12618000432213
- Lead Sponsor
- Professor Bernhard Breier (Chair in Human Nutrition)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 272
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link gut microbiome composition to obesity prevention in ACTRN12618000432213?
How does gut microbiome modulation compare to standard-of-care for metabolic syndrome treatment?
Which specific gut microbiome biomarkers predict metabolic health outcomes in observational studies?
What adverse events are associated with gut microbiome interventions for obesity management?
Are there combination therapies involving probiotics and GLP-1 agonists for metabolic disease?